New York Personal Injury Attorney Blog

On April 1st, the Food and Drug Administration (FDA) announced its request for all prescription and over-the-counter ranitidine drugs to be removed from the market immediately. This decision was made based on an ongoing investigation of the potential risk of N-nitrosodimethylamine, or NDMA, to public health. Here, the product liability attorneys at Sullivan Papain Block…

After decades of lax regulation of talc-based products and cosmetics, the FDA has decided to improve testing to eliminate the risk of cancerous carcinogens in consumer goods. This issue, outlined in a recent Reuters report, brings into question the validity of self-regulation in the consumer product industry, especially with the looming risk of cancer. Here,…

As a result of FDA tests that found traces of N-nitrosodimethylamine, or NDMA, in Zantac and other forms of ranitidine, major drug manufacturer Sanofi voluntarily issued a recall of the popular heartburn medication. Here, the pharmaceutical liability attorneys at Sullivan Papain Block McManus Coffinas & Cannavo, P.C. provide recent updates on this massive recall as…

Johnson & Johnson has recalled 33,000 bottles of baby powder after the Food and Drug Administration (FDA) recently found asbestos in a bottle purchased online. Here, the product liability attorneys at Sullivan Papain Block McManus Coffinas & Cannavo, P.C. discuss these latest developments. Johnson & Johnson Baby Powder from Affected Lot Recalled from the Market …

As a result of the discovery of the cancer-causing N-nitrosodimethylamine (NDMA) found in Zantac, manufacture and shipment of both the generic and branded forms of Zantac have been halted by Sandoz, Novartis and GlaxoSmithKline Plc. Here, the pharmaceutical liability attorneys at Sullivan Papain Block McManus Coffinas & Cannavo P.C. discuss recent updates to this global…